[Insulin resistance in polycystic ovary syndrome]

Wien Klin Wochenschr. 2003 Dec 15;115(23):812-21. doi: 10.1007/BF03041041.
[Article in German]

Abstract

With a prevalence of 5-10% the polycystic ovary syndrome (PCOS) is a common disorder of premenopausal women. According to prospective studies abnormal glucose tolerance and diabetes mellitus present in about 10.0% and 35.0% of adult women with PCOS, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension and dyslipidaemia. The rate of spontaneous abortions as well as the risk of developing gestational diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem, but a complex endocrine disease with important health implications. The role of glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Body Mass Index
  • Cardiovascular Diseases / etiology
  • Chromans / therapeutic use
  • Controlled Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes, Gestational / etiology
  • Female
  • Glucose / metabolism
  • Glucose Intolerance
  • Glucose Tolerance Test
  • Humans
  • Hyperlipidemias / epidemiology
  • Hypertension / epidemiology
  • Hypoglycemic Agents / therapeutic use
  • Infant, Newborn
  • Infertility, Female / etiology
  • Insulin Resistance*
  • Metformin / therapeutic use
  • Middle Aged
  • Obesity / complications
  • Placebos
  • Polycystic Ovary Syndrome / complications*
  • Polycystic Ovary Syndrome / drug therapy
  • Polycystic Ovary Syndrome / metabolism
  • Polycystic Ovary Syndrome / physiopathology
  • Pregnancy
  • Premenopause
  • Prevalence
  • Prospective Studies
  • Retrospective Studies
  • Risk Factors
  • Thiazolidinediones / therapeutic use
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Placebos
  • Thiazolidinediones
  • Metformin
  • Troglitazone
  • Glucose